1. Home
  2. IPAR vs TVTX Comparison

IPAR vs TVTX Comparison

Compare IPAR & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inter Parfums Inc.

IPAR

Inter Parfums Inc.

HOLD

Current Price

$91.73

Market Cap

2.9B

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$40.25

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPAR
TVTX
Founded
1982
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
IPAR
TVTX
Price
$91.73
$40.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
13
Target Price
$116.60
$40.46
AVG Volume (30 Days)
223.0K
2.3M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
3.51%
N/A
EPS Growth
2.34
92.89
EPS
5.24
N/A
Revenue
$1,317,700,000.00
N/A
Revenue This Year
$3.86
$44.76
Revenue Next Year
$7.89
$35.51
P/E Ratio
$17.37
N/A
Revenue Growth
21.26
N/A
52 Week Low
$77.21
$13.88
52 Week High
$142.50
$43.31

Technical Indicators

Market Signals
Indicator
IPAR
TVTX
Relative Strength Index (RSI) 44.72 65.65
Support Level $87.60 $32.62
Resistance Level $99.02 $42.06
Average True Range (ATR) 2.84 2.14
MACD -0.11 0.56
Stochastic Oscillator 27.67 80.49

Price Performance

Historical Comparison
IPAR
TVTX

About IPAR Inter Parfums Inc.

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: